share_log

歐康維視生物-B:(1)更新計劃授權限額及確認服務提供者分項限額;(2)有關建議關連授出之關連交易及向僱員參與者授出;及(3)股東特別大會通告

Ocumension Therapeutics-B: (1) REFRESHMENT OF THE SCHEME MANDATE LIMIT AND SET OF THE SERVICE PROVIDER SUBLIMIT; (2) GRANT TO EMPLOYEE PARTICIPANTS AND CONNECTED TRANSACTION INVOLVING THE PROPOSED CONNECTED GRANT; AND (3) NOTICE OF EXTRAORDINARY GENERAL ME

Nov 3, 2022 19:05
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more